IDXX

SELL

IDEXX Laboratories, Inc.

Healthcare · Rank #129 · Analyzed Apr 20, 2026

$589.25

Current Price

$240.63

Intrinsic Value

-27.9%

Upside/Downside

4/10

Score

4/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score4/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 27.9%

Fair Value Range

Low$16.17

Base (IV)$240.63

High$424.60

Entry Points

Conservative$16.17

Moderate$128.40

Aggressive$240.63

Quality & Moat Breakdown

Return on Equity66.2% → 1.0/1.0

Debt LevelD/E 61 → 0/1.0

Revenue QualityGrowth 8.3%, margin Δ+5.1% → 1.0/1.0

Moat Strength4.0/5 → 1.0/1.0

Profit Margins24.6% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.